Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line

Sae-Byeol Choi, Jong Bae Park, Taejin Song, Sang Yong Choi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that plays a central role in the hypoxic expression of various genes. Vascular endothelial growth factor (VEGF), a known target gene of HIF-1α, has been shown to be induced by hypoxia through a HIF-1α-independent pathway. HIF-1α dominant-negative lentiviral vectors were introduced to decrease the expression of HIF in Hep3B cells. Cells were incubated under normoxic or hypoxic conditions. We performed a VEGF enzyme-linked immunosorbent assay (ELISA) using cell culture supernatants, and Western blotting using cell lysates. To validate signaling via HIF-1-dependent or HIF-1-independent pathways, we treated cells with an extracellular signal-regulated kinase (ERK) kinase inhibitor, a phosphoinositide 3-kinase (PI3K) inhibitor, and transfected cells with siSP1. HIF-1α protein expression was induced and the levels of VEGF increased under hypoxic conditions. Cells were transfected with siHIF-1α and incubated under normoxic or hypoxic conditions. We found that a significant amount of VEGF was produced by a HIF-1-independent pathway. PI3K inhibitor treatment and siSP1 transient transfection decreased VEGF expression in siHIF-1α-transfected cells. Therefore, VEGF regulation in Hep3B cells is primarily controlled by the Akt/PI3K and SP1 pathways and is independent of HIF-1 under hypoxic conditions.

Original languageEnglish
Pages (from-to)449-454
Number of pages6
JournalInternational Journal of Molecular Medicine
Volume28
Issue number3
DOIs
Publication statusPublished - 2011 Sep 1

Fingerprint

Hypoxia-Inducible Factor 1
Vascular Endothelial Growth Factor A
Hepatocellular Carcinoma
Cell Line
1-Phosphatidylinositol 4-Kinase
Extracellular Signal-Regulated MAP Kinases
Transfection
Transcription Factors
Phosphotransferases
Cell Culture Techniques
Western Blotting
Enzyme-Linked Immunosorbent Assay
Gene Expression

Keywords

  • Angiogenesis
  • Hep3B cell line
  • Hepatocellular carcinoma
  • Hypoxia-inducible factor-1
  • SP1
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Genetics

Cite this

Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line. / Choi, Sae-Byeol; Park, Jong Bae; Song, Taejin; Choi, Sang Yong.

In: International Journal of Molecular Medicine, Vol. 28, No. 3, 01.09.2011, p. 449-454.

Research output: Contribution to journalArticle

@article{2f6bd030115f4d60a30ce2c5e52ca699,
title = "Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line",
abstract = "Hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that plays a central role in the hypoxic expression of various genes. Vascular endothelial growth factor (VEGF), a known target gene of HIF-1α, has been shown to be induced by hypoxia through a HIF-1α-independent pathway. HIF-1α dominant-negative lentiviral vectors were introduced to decrease the expression of HIF in Hep3B cells. Cells were incubated under normoxic or hypoxic conditions. We performed a VEGF enzyme-linked immunosorbent assay (ELISA) using cell culture supernatants, and Western blotting using cell lysates. To validate signaling via HIF-1-dependent or HIF-1-independent pathways, we treated cells with an extracellular signal-regulated kinase (ERK) kinase inhibitor, a phosphoinositide 3-kinase (PI3K) inhibitor, and transfected cells with siSP1. HIF-1α protein expression was induced and the levels of VEGF increased under hypoxic conditions. Cells were transfected with siHIF-1α and incubated under normoxic or hypoxic conditions. We found that a significant amount of VEGF was produced by a HIF-1-independent pathway. PI3K inhibitor treatment and siSP1 transient transfection decreased VEGF expression in siHIF-1α-transfected cells. Therefore, VEGF regulation in Hep3B cells is primarily controlled by the Akt/PI3K and SP1 pathways and is independent of HIF-1 under hypoxic conditions.",
keywords = "Angiogenesis, Hep3B cell line, Hepatocellular carcinoma, Hypoxia-inducible factor-1, SP1, Vascular endothelial growth factor",
author = "Sae-Byeol Choi and Park, {Jong Bae} and Taejin Song and Choi, {Sang Yong}",
year = "2011",
month = "9",
day = "1",
doi = "10.3892/ijmm.2011.719",
language = "English",
volume = "28",
pages = "449--454",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line

AU - Choi, Sae-Byeol

AU - Park, Jong Bae

AU - Song, Taejin

AU - Choi, Sang Yong

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that plays a central role in the hypoxic expression of various genes. Vascular endothelial growth factor (VEGF), a known target gene of HIF-1α, has been shown to be induced by hypoxia through a HIF-1α-independent pathway. HIF-1α dominant-negative lentiviral vectors were introduced to decrease the expression of HIF in Hep3B cells. Cells were incubated under normoxic or hypoxic conditions. We performed a VEGF enzyme-linked immunosorbent assay (ELISA) using cell culture supernatants, and Western blotting using cell lysates. To validate signaling via HIF-1-dependent or HIF-1-independent pathways, we treated cells with an extracellular signal-regulated kinase (ERK) kinase inhibitor, a phosphoinositide 3-kinase (PI3K) inhibitor, and transfected cells with siSP1. HIF-1α protein expression was induced and the levels of VEGF increased under hypoxic conditions. Cells were transfected with siHIF-1α and incubated under normoxic or hypoxic conditions. We found that a significant amount of VEGF was produced by a HIF-1-independent pathway. PI3K inhibitor treatment and siSP1 transient transfection decreased VEGF expression in siHIF-1α-transfected cells. Therefore, VEGF regulation in Hep3B cells is primarily controlled by the Akt/PI3K and SP1 pathways and is independent of HIF-1 under hypoxic conditions.

AB - Hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that plays a central role in the hypoxic expression of various genes. Vascular endothelial growth factor (VEGF), a known target gene of HIF-1α, has been shown to be induced by hypoxia through a HIF-1α-independent pathway. HIF-1α dominant-negative lentiviral vectors were introduced to decrease the expression of HIF in Hep3B cells. Cells were incubated under normoxic or hypoxic conditions. We performed a VEGF enzyme-linked immunosorbent assay (ELISA) using cell culture supernatants, and Western blotting using cell lysates. To validate signaling via HIF-1-dependent or HIF-1-independent pathways, we treated cells with an extracellular signal-regulated kinase (ERK) kinase inhibitor, a phosphoinositide 3-kinase (PI3K) inhibitor, and transfected cells with siSP1. HIF-1α protein expression was induced and the levels of VEGF increased under hypoxic conditions. Cells were transfected with siHIF-1α and incubated under normoxic or hypoxic conditions. We found that a significant amount of VEGF was produced by a HIF-1-independent pathway. PI3K inhibitor treatment and siSP1 transient transfection decreased VEGF expression in siHIF-1α-transfected cells. Therefore, VEGF regulation in Hep3B cells is primarily controlled by the Akt/PI3K and SP1 pathways and is independent of HIF-1 under hypoxic conditions.

KW - Angiogenesis

KW - Hep3B cell line

KW - Hepatocellular carcinoma

KW - Hypoxia-inducible factor-1

KW - SP1

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=79959968571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959968571&partnerID=8YFLogxK

U2 - 10.3892/ijmm.2011.719

DO - 10.3892/ijmm.2011.719

M3 - Article

C2 - 21667015

AN - SCOPUS:79959968571

VL - 28

SP - 449

EP - 454

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 3

ER -